Gilead Sciences’ seladelpar has won conditional marketing authorization to treat primary biliary cholangitis (PBC) alongside ...

Sciences announced that the European Commission (EC) has granted conditional marketing authorization for seladelpar for the ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the European Commission (EC) has granted conditional marketing authorization for seladelpar for the treatment of primary biliary ...

--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the European Commission (EC) has granted conditional marketing authorization for seladelpar for the treatment of ...

(RTTNews) - Gilead Sciences Inc. (GILD) announced that the European Commission has granted conditional marketing authorization for seladelpar for the treatment of primary biliary cholangitis in ...

Gilead Sciences (GILD) said on Friday that the European Commission (EC) granted conditional marketing authorization for ...

The American quant hedge fund Renaissance Technologies is known for using statistical and mathematical tools to drive its ...

The Digital Cooperation Organization (DCO), the world's first standalone international intergovernmental organization focusing on the acceleration of the growth of an inclusive and sustainable digital ...

Be sure to come back regularly for the latest updates. The approval covers seladelpar's use in combination with ursodeoxycholic acid (UDCA) for those who have an inadequate response to UDCA alone ...

Pacific Green Technologies, Inc. ("Pacific Green", OTCQB: PGTK) announces that it has signed binding documentation for the sale of 100% of the shares in its Limestone Coast North Energy Park to Intera ...